Within subject variability [Power / Sample Size]

posted by MaggieSantos – Portugal, 2018-03-15 23:51 (2289 d 17:32 ago) – Posting: # 18558
Views: 4,280

Dear all,

I am exploring the hypothesis to use the within subject variability obtained on conventional 2 way crossover bioequivalence study and apply it in scale average bioequivalence as described for a replicated design used for HVD or NTI.
I know that within subject variability of reference would be necessary, but I have no replicated design. My doubt is if these values have any relation somehow like, for instance, the first one is larger than the second one or there is no relationship at all?

Kind Regards

MaggieSantos


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,665 registered users;
35 visitors (0 registered, 35 guests [including 9 identified bots]).
Forum time: 18:24 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5